Long-acting amylin analog that activates amylin receptors in the hypothalamus to reduce food intake and slow gastric emptying.
For athletes, the primary value of Cagrilintide lies in its ability to appetite control and weight management, especially synergistic with glp-1 agonists.. This mechanism is particularly relevant during high-volume training phases when tissue repair demand exceeds the body's natural recovery capacity.
Variable — onset typically within 2–8 weeks depending on protocol and individual response.
Individual response varies based on injury severity, training load, and baseline health markers.
Similar GI side effect profile to GLP-1 agonists. Nausea most common.
Always verify current WADA status with your sport's governing body before use in competition.
https://pubmed.ncbi.nlm.nih.gov/34986328/
Start a Cagrilintide Protocol
Hatter Labs provides physician-supervised performance protocols with GMP-certified Cagrilintide and comprehensive biomarker monitoring.
Get ProtocolCompare & Stack
Start Your Performance Protocol for Cagrilintide
Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.
HIPAA Compliant · GMP Certified · Physician Supervised